{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treatment of Life-Threatening ACE-Inhibitor Induced Angioedema

Activity Steps

Purpose of Activity

To describe the incidence and pathophysiology of ACE-inhibitor?induced angioedema (ACE-I AE) and its treatment strategies.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recall the incidence, cause, sequelae, and mortality of ACE-I AE.
  2. Recognize pathology, symptoms, and risk for ACE-I AE.
  3. Identify treatment for ACE-I AE.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: AENJ1018
Published: Oct/Dec 2018
Expires: 9/3/2021
Required Passing Score: 14/18 (77%)
Authors: RaeAnn Hirschy, PharmD, BCPS; Tanvi Shah, PharmD, BCPS; Tamara Davis, PharmD, BCPS; Megan A. Rech, PharmD, MSc, BCPS, BCCCP